Ledger.Open graph →

SEC Form D · Amendment · filed August 12, 2009

ARRAY BIOPHARMA INC

Offering

—

Sold

—

Exemption

—

Industry

Biotechnology

Location

BOULDER, CO

Type

—

People & firms on this filing (22)

Kyle A. Lefkoff · Boulder, CODirector Robert E. Conway · Boulder, COExec · Director Marvin H. Caruthers · Boulder, CODirector John L. Zabriskie · Boulder, CODirector Kevin Koch · Boulder, COExec · Director John R. Moore · Boulder, COExec Gil J. Van Lunsen · Boulder, CODirector Douglas E. Williams · Boulder, CODirector Francis J. Bullock · Boulder, CODirector David Snitnam · Boulder, COExec · Director R. M. Carruthers · Boulder, COExec Daren Mccormick · Birmingham, ALExec · Director Don Johnson · Birmingham, ALExec Emerson Fann · Birmingham, ALExec · Director Kenneth Kizer · Carlsbad, CAExec · Director Larry Augustin · Carlsbad, CAExec Nicholaus Efstratis · Salt Lake City, UTDirector Randall Prust · Carlsbad, CADirector Mike Kwatinez · Carlsbad, CADirector Michael Doyle · Carlsbad, CADirector Mark Czepiel · Carlsbad, CADirector Rick Jung · Carlsbad, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗